{
    "Trade/Device Name(s)": [
        "Alere\u2122 i Influenza A & B",
        "Alere\u2122 i flu",
        "Alere\u2122 i",
        "Alere\u2122 Influenza A & B"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K141520",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111387"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "001"
    ],
    "Summary Letter Date": "June 13, 2014",
    "Summary Letter Received Date": "June 9, 2014",
    "Submission Date": "June 6, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "POCT"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "Universal Transport Medium (UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "Alere\u2122 i Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification",
        "Fluorescent molecular beacon detection"
    ],
    "Methodologies": [
        "Molecular amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Reagent",
        "Cartridge",
        "Component",
        "Reader",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Alere\u2122 i Influenza A & B rapid isothermal amplification assay and instrument for qualitative detection and differentiation of influenza A and B viral RNA from nasal swabs",
    "Indications for Use Summary": "Aids in rapid, qualitative detection and differentiation of influenza A and B viral RNA in nasal swabs from patients with respiratory infection signs and symptoms; used in conjunction with clinical and epidemiological risk factors; not for detection of influenza C.",
    "fda_folder": "Microbiology"
}